Spiral computed tomography screening: Study begins to determine its efficacy in lung cancer prevention

od Kramer, Barnett S
Wydane 2001

Paradoxes in carcinogenesis: New opportunities for research directions

od Kramer Barnett S, Baker Stuart G
Wydane 2007-08-01

The transitive fallacy for randomized trials: If A bests B and B bests C in separate trials, is A better than C?

od Baker, Stuart G, Kramer, Barnett S
Wydane 2002

Randomized trials, generalizability, and meta-analysis: Graphical insights for binary outcomes

od Baker, Stuart G, Kramer, Barnett S
Wydane 2003

A perfect correlate does not a surrogate make

od Baker, Stuart G, Kramer, Barnett S
Wydane 2003

Correction: The transitive fallacy for randomized trials: If A bests B and B bests C in separate trials, is A better than C?

od Baker, Stuart G, Kramer, Barnett S
Wydane 2003

Identifying genes that contribute most to good classification in microarrays

od Baker, Stuart G, Kramer, Barnett S
Wydane 2006

Paradoxes in carcinogenesis: New opportunities for research directions

od Baker, Stuart G, Kramer, Barnett S
Wydane 2007

Using microarrays to study the microenvironment in tumor biology: The crucial role of statistics

od Baker, Stuart G., Kramer, Barnett S.
Wydane 2008

Systems Biology and Cancer: Promises and Perils

od Baker, Stuart G., Kramer, Barnett S.
Wydane 2011

Surrogate Endpoint Analysis: An Exercise in Extrapolation

od Baker, Stuart G., Kramer, Barnett S.
Wydane 2013

The risky reliance on small surrogate endpoint studies when planning a large prevention trial

od Baker, Stuart G., Kramer, Barnett S.
Wydane 2012

Evaluating surrogate endpoints, prognostic markers, and predictive markers — some simple themes

od Baker, Stuart G., Kramer, Barnett S.
Wydane w Clin Trials (2014)

Evaluating Prognostic Markers Using Relative Utility Curves and Test Tradeoffs

od Baker, Stuart G., Kramer, Barnett S.
Wydane w J Clin Oncol (2015)

Lung Cancer Risk and Demographic Characteristics of Current 20–29 Pack-Year Smokers: Implications for Screening

od Pinsky, Paul F., Kramer, Barnett S.
Wydane w J Natl Cancer Inst (2015)

Cancer Prevention: Lessons Learned and Future Directions

od Dunn, Barbara K., Kramer, Barnett S.
Wydane w Trends Cancer (2016)

Simple Methods for Evaluating 4 Types of Biomarkers: Surrogate Endpoint, Prognostic, Predictive, and Cancer Screening

od Baker, Stuart G, Kramer, Barnett S
Wydane w Biomark Insights (2020)

The fallacy of enrolling only high-risk subjects in cancer prevention trials: Is there a "free lunch"?

od Corle Donald, Kramer Barnett S, Baker Stuart G
Wydane 2004-10-01

The Paired Availability Design for Historical Controls

od Baker, Stuart G, Lindeman, Karen S, Kramer, Barnett S
Wydane 2001

Markers for early detection of cancer: Statistical guidelines for nested case-control studies

od Baker, Stuart G, Kramer, Barnett S, Srivastava, Sudhir
Wydane 2002